The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.


Updates from The Motley Fool

Latest updates on Regeneron Pharmaceuticals from Fool.com.  The Fool has written over 300 articles on Regeneron Pharmaceuticals.
3 Growth Stocks I'd Buy Right Now

Here's why I think growth stock Skyworks Solutions, Regeneron Pharmaceuticals, and Under Armour a...

2 Top Stocks in Biotech

An increasingly strict FDA has made these great biotech stocks even more attractive than usual.



Stock Performance

View Interactive REGN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Regeneron Pharmaceuticals.
Current Price: $373.00
Prev Close: $365.02
Open: $367.92
Bid: $358.00
Ask: $372.00
Day's Range: $366.72 - $374.85
52wk Range: $325.35 - $452.96
Volume: 880,540
Avg Vol 917,240
Market Cap: $40B
P/E (ttm): 47.41
EPS (ttm): $7.70
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Regeneron Pharmaceuticals.
CAPS Rating 4 out of 5
 
401 Outperform
73 Underperform
CAPS All Stars
 
86 Outperform
14 Underperform

How do you think Regeneron Pharmaceuticals will perform against the market?



You pick for Regeneron Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Leonard S. Schleifer, CEO

94% Approve

Based on 194 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Regeneron Pharmaceuticals.

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers